nach oben

Herzschrittmachertherapie + Elektrophysiologie

Erschienen in:

09.05.2023 | Reviews

Circulating magnesium as a potential risk stratification tool for sudden cardiac death: a systematic review

verfasst von: Edward Davis, BMed, Bernard C. Fernando, BMed, Louis Fabio Jonathan Jusni, BMed, Kevin R. Hendryan, BMed, Rexel Kuatama, BMed, Dr. Med. Denio A. Ridjab, MD, FESC

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Sudden cardiac death (SCD) is one of the main causes of cardiovascular mortality and accounts for 15–20% of deaths worldwide. The current stratification strategy using depressed left ventricular ejection fraction is insufficient to stratify the risk of SCD, especially in the general population. In recent years, there has been increasing evidence showing the antiarrhythmic properties of magnesium. In this systematic review, the authors aim to determine circulating magnesium as a potential risk stratification tool for SCD.

Methods

This systematic review was based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and was conducted in July 2021 with sources from Google Scholar, PubMed, Science Direct, EBSCO Medline, and ProQuest.

Results

A total of six studies were included in this review. Three studies conducted in the general population consistently showed lower risk of SCD in populations with high circulating magnesium. There was no association between circulating magnesium level and risk of SCD in intensive cardiac care unit (ICCU) patients, whilst the results were conflicting in congestive heart failure (CHF) patients.

Conclusion

High circulating magnesium might have the potential to be utilized as a risk stratification tool for SCD, especially in the general population. However, further study is needed to support this evidence.

Mozaffarian D, Benjamin E, Go A, Arnett D, Blaha M, Cushman M et al (2015) Heart disease and stroke statistics—2015 update. Circulation. https://doi.org/10.1161/cir.0000000000000152CrossRefPubMedPubMedCentral

Hayashi M, Shimizu W, Albert C (2015) The spectrum of epidemiology underlying sudden cardiac death. Circ Res 116(12):1887–1906. https://doi.org/10.1161/circresaha.116.304521CrossRefPubMedPubMedCentral

Wong C, Brown A, Lau D, Chugh S, Albert C, Kalman J et al (2019) Epidemiology of sudden cardiac death: global and regional perspectives. Heart Lung Circ 28(1):6–14. https://doi.org/10.1016/j.hlc.2018.08.026CrossRefPubMed

Adabag AS, Luepker RV, Roger VL, Gersh BJ (2010) Sudden cardiac death: epidemiology and risk factors. Nat Rev Cardiol 7(4):216–225. https://doi.org/10.1038/nrcardio.2010.3CrossRefPubMedPubMedCentral

Huikuri H (2011) Prediction and prevention of sudden cardiac arrest. CMAJ 183(15):1692–1693. https://doi.org/10.1503/cmaj.111245CrossRefPubMedPubMedCentral

Fishman G, Chugh S, DiMarco J, Albert C, Anderson M, Bonow R et al (2010) Sudden cardiac death prediction and prevention. Circulation 122(22):2335–2348. https://doi.org/10.1161/CIRCULATIONAHA.110.976092CrossRefPubMedPubMedCentral

Fiorentini D, Cappadone C, Farruggia G, Prata C (2021) Magnesium: biochemistry, nutrition, detection, and social impact of diseases linked to its deficiency. Nutrients 13(4):1136. https://doi.org/10.3390/nu13041136CrossRefPubMedPubMedCentral

Jahnen-Dechent W, Ketteler M (2012) Magnesium basics. Clin Kidney J 5(1):i3–i14. https://doi.org/10.1093/ndtplus/sfr163CrossRefPubMedPubMedCentral

DiNicolantonio J, Liu J, O’Keefe J (2018) Magnesium for the prevention and treatment of cardiovascular disease. Open Heart 5(2):e775. https://doi.org/10.1136/openhrt-2018-000775CrossRefPubMedPubMedCentral

10.

Tangvoraphonkchai K, Davenport A (2018) Magnesium and cardiovascular disease. Adv Chronic Kidney Dis 25(3):251–260. https://doi.org/10.1053/j.ackd.2018.02.010CrossRefPubMed

11.

National Heart, Lung, and Blood Institute (2021) Quality assessment tool for observational cohort and cross-sectional studies. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed 20 Nov 2021

12.

National Heart, Lung, and Blood Institute (2021) Quality assessment of case-control studies. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed 20 Nov 2021

13.

Chiuve SE, Korngold EC, Januzzi JL Jr, Gantzer ML, Albert CM (2011) Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr 93:253–260. https://doi.org/10.3945/ajcn.110.00225CrossRefPubMed

14.

Kieboom B, Niemeijer M, Leening M, van den Berg M, Franco O, Deckers J et al (2016) Serum magnesium and the risk of death from coronary heart disease and sudden cardiac death. J Am Heart Assoc. https://doi.org/10.1161/jaha.115.002707CrossRefPubMedPubMedCentral

15.

Peacock J, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folsom A (2010) Serum magnesium and risk of sudden cardiac death in the atherosclerosis risk in communities (ARIC) study. Am Heart J 160(3):464–470. https://doi.org/10.1016/j.ahj.2010.06.012CrossRefPubMedPubMedCentral

16.

Naksuk N, Hu T, Krittanawong C, Thongprayoon C, Sharma S, Park J et al (2017) Association of serum magnesium on mortality in patients admitted to the intensive cardiac care unit. Am J Med 130(2):229.e5–229.e13. https://doi.org/10.1016/j.amjmed.2016.08.033CrossRefPubMed

17.

Eichhorn E, Tandon P, Dibianco R, Timmis G, Fenster P, Shannon J et al (1993) Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the promise study. J Am Coll Cardiol 21(3):634–640. https://doi.org/10.1016/0735-1097(93)90095-iCrossRefPubMed

18.

Madsen B, Rasmussen V, Hansen J (1997) Predictors of sudden death and death from pump failure in congestive heart failure are different. Analysis of 24 h Holter monitoring, clinical variables, blood chemistry, exercise test and radionuclide angiography. Int J Cardiol 58(2):151–162. https://doi.org/10.1016/s0167-5273(96)02853-7CrossRefPubMed

19.

Goldberger J, Cain M, Hohnloser S, Kadish A, Knight B, Lauer M et al (2008) American heart association/American college of cardiology foundation/heart rhythm society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American heart association council on clinical cardiology committee on electrocardiography and arrhythmias and council on epidemiology and prevention. Circulation 118(14):1497–1518CrossRefPubMed

20.

Goldberger JJ, Buxton AE, Cain M, Costantini O, Exner DV, Knight BP et al (2011) Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks. Circulation 123(21):2423–2430CrossRefPubMed

21.

Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S (2002) Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem 238(1):163–179. https://doi.org/10.1023/a:1019998702946CrossRefPubMed

22.

Fazekas T, Scherlag BJ, Vos M, Wellens HJ, Lazzara R (1993) Magnesium and the heart: antiarrhythmic therapy with magnesium. Clin Cardiol 16(11):768–774. https://doi.org/10.1002/clc.4960161105CrossRefPubMed

23.

Williamson M, Snyder L (2011) Wallach’s interpretation of diagnostic tests. Wolters Kluwer/Lippincott Williams & Wilkins Health, Philadelphia

24.

Fiset C, Kargacin ME, Kondo CS, Lester WM, Duff HJ (1996) Hypomagnesemia: characterization of a model of sudden cardiac death. J Am Coll Cardiol 27(7):1771–1776. https://doi.org/10.1016/0735-1097(96)00089-7CrossRefPubMed

25.

Cannon LA, Heiselman DE, Dougherty JM, Jones J (1987) Magnesium levels in cardiac arrest victims: relationship between magnesium levels and successful resuscitation. Ann Emerg Med 16(11):1195–1199. https://doi.org/10.1016/s0196-0644(87)80222-6CrossRefPubMed

26.

Zhang X, Del Gobbo L, Hruby A, Rosanoff A, He K, Dai Q et al (2016) The circulating concentration and 24‑h urine excretion of magnesium dose- and time-dependently respond to oral magnesium supplementation in a meta-analysis of randomized controlled trials. J Nutr 146(3):595–602. https://doi.org/10.3945/jn.115.223453CrossRefPubMed

27.

Li J, Hovey K, Andrews C, Quddus A, Allison M, Van Horn L et al (2020) Association of dietary magnesium intake with fatal coronary heart disease and sudden cardiac death. J Womens Health (Larchmt) 29(1):7–12. https://doi.org/10.1089/jwh.2019.777CrossRefPubMed

28.

Haigney M, Silver B, Tanglao E, Silverman H, Hill J, Shapiro E et al (1995) Noninvasive measurement of tissue magnesium and correlation with cardiac levels. Circulation 92(8):2190–2197. https://doi.org/10.1161/01.cir.92.8.2190CrossRefPubMed

29.

Ralston M, Murnane M, Kelley R, Altschuld R, Unverferth D, Leier C (1989) Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure. Circulation 80(3):573–580. https://doi.org/10.1161/01.cir.80.3.573CrossRefPubMed

Titel: Circulating magnesium as a potential risk stratification tool for sudden cardiac death: a systematic review
verfasst von: Edward Davis, BMed
Bernard C. Fernando, BMed
Louis Fabio Jonathan Jusni, BMed
Kevin R. Hendryan, BMed
Rexel Kuatama, BMed
Dr. Med. Denio A. Ridjab, MD, FESC
Publikationsdatum: 09.05.2023
Verlag: Springer Medizin
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 2/2023
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI: https://doi.org/10.1007/s00399-023-00941-8

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2023

Plötzlicher Herztod nach Kardioversion

Behandlung asymptomatischer Arrhythmien im digitalen Zeitalter

Asymptomatische Ionenkanalerkrankungen

Asymptomatische ventrikuläre Extrasystolen behandeln?